JPMorgan Chase & Co. Analysts Give Roche (ROG) a CHF 300 Price Target

Roche (VTX:ROG) has been assigned a CHF 300 target price by JPMorgan Chase & Co. in a report released on Thursday. The firm presently has a “buy” rating on the healthcare company’s stock. JPMorgan Chase & Co.’s price target suggests a potential upside of 19.47% from the stock’s previous close.

ROG has been the subject of a number of other reports. Goldman Sachs Group set a CHF 325 target price on Roche and gave the stock a “buy” rating in a research report on Thursday, October 12th. Morgan Stanley set a CHF 260 target price on Roche and gave the stock a “neutral” rating in a research report on Friday, November 17th. Deutsche Bank set a CHF 264 target price on Roche and gave the stock a “neutral” rating in a research report on Tuesday, December 12th. Liberum Capital set a CHF 279 target price on Roche and gave the stock a “buy” rating in a research report on Wednesday, November 22nd. Finally, Baader Bank set a CHF 231 price target on Roche and gave the stock a “neutral” rating in a report on Thursday, October 19th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of CHF 262.89.

Shares of Roche (ROG) opened at CHF 251.10 on Thursday. Roche has a 52-week low of CHF 226.10 and a 52-week high of CHF 273. The stock has a market capitalization of $216,540.00 and a price-to-earnings ratio of 22.32.

TRADEMARK VIOLATION WARNING: “JPMorgan Chase & Co. Analysts Give Roche (ROG) a CHF 300 Price Target” was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://www.chaffeybreeze.com/2018/01/04/jpmorgan-chase-co-analysts-give-roche-rog-a-chf-300-price-target.html.

Roche Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche (VTX:ROG)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply